Mohammad Barzegar-Jalali

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Magnetic Nanoparticles

Top Venues

BioImpacts : BI

Nanomedicine (London, England)

Advanced pharmaceutical bulletin

This page only lists publications with an associated author ORCID identifier.

Publications

Fatima Molavi, Mohammad Barzegar-Jalali, Hamed Hamishehkar
Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres. BioImpacts : BI 12 (6) (2022)
Fatima Molavi, Mohammad Barzegar-Jalali, Hamed Hamishehkar
Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres. BioImpacts : BI 12 (6) (2022)
Nastaran Hashemzadeh, Mitra Dolatkhah, Ayuob Aghanejad, Mohammad Barzegar-Jalali, Yadollah Omidi, Khosro Adibkia, Morteza Mahmoudi
Folate receptor-mediated delivery of 1-MDT-loaded mesoporous silica magnetic nanoparticles to target breast cancer cells. Nanomedicine (London, England) 16 (24) (2021)
Mitra Dolatkhah, Nastaran Hashemzadeh, Morteza Mahmoudi, Khosro Adibkia, Ayuob Aghanejad, Mohammad Barzegar-Jalali, Hossein Omidian, Yadollah Omidi
Stimuli-responsive graphene oxide and methotrexate-loaded magnetic nanoparticles for breast cancer-targeted therapy. Nanomedicine (London, England) 16 (24) (2021)
Khosro Adibkia, Sevil Selselehjonban, Shahram Emami, Karim Osouli-Bostanabad, Mohammad Barzegar-Jalali
Electrosprayed polymeric nanobeads and nanofibers of modafinil: preparation, characterization, and drug release studies. BioImpacts : BI 9 (3) (2019)
Khosro Adibkia, Solmaz Ghajar, Karim Osouli-Bostanabad, Niloufar Balaei, Shahram Emami, Mohammad Barzegar-Jalali
Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation. Advanced pharmaceutical bulletin 9 (2) (2019)